Search - tctmd.com

Displaying 1 - 20 of 102

Sort: Relevancy | Date

Presentation TCT 2016

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Presenter: Martin W. Bergmann, Samir R. Kapadia, Vivek Y. Reddy

November 01, 2016

Presentation TCT 2016

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Martin W. Bergmann, Samir R. Kapadia, Harvey D. White

November 01, 2016

Presentation TCT 2016

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Presenter: Martin W. Bergmann, Samir R. Kapadia, Jason H. Rogers

November 01, 2016

Presentation TCT 2016

Is LAA Closure an Alternative to Triple Therapy for all Patients or Those at High Bleeding Risk? Current Dataset

Presenter: Martin W. Bergmann, Samir R. Kapadia, Brian K. Whisenant

November 01, 2016

Presentation TCT 2016

Why Triple Therapy? Rationale and Potential Role for LAA Closure in the PCI Patient

Presenter: Martin W. Bergmann, Samir R. Kapadia, Ashish Pershad

November 01, 2016

Presentation TCT 2016

Future Therapy for Symptomatic HCM Patients With and Without Dynamic Obstruction

Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Septal Ablation Is As Good As Surgery and Less Invasive!

Presenter: George S. Hanzel, Antoine Lafont, Carey D. Kimmelstiel

October 30, 2016

Presentation TCT 2016

Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Surgery Is Always the First Option!

Presenter: George S. Hanzel, Antoine Lafont, Daniel G Swistel

October 30, 2016

Presentation TCT 2016

Debate: Surgery, Septal Ablation or Medical Therapy for Obstructive HCM Not so Fast: Try Optimizing Medical Therapy First!

Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Novel Approaches for Septal Ablation: Beyond Alcohol

Presenter: Srihari S. Naidu, Paul Sorajja

October 30, 2016

Presentation TCT 2016

Alcohol Septal Ablation of Ventricular Tachycardia

Presenter: Srihari S. Naidu, Paul Sorajja, George D. Dangas

October 30, 2016

Presentation TCT 2016

An Alcohol Septal Ablation Case I Regret

Presenter: Srihari S. Naidu, Paul Sorajja

October 30, 2016

Presentation TCT 2016

My Best Alcohol Septal Ablation Case

Presenter: Srihari S. Naidu, Paul Sorajja, George S. Hanzel

October 30, 2016

Presentation TCT 2016

Good and Not So Good Cases to Consider for Alcohol Septal Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, John S. Douglas Jr

October 30, 2016

Presentation TCT 2016

Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Vivek Y. Reddy

October 30, 2016

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Presenter: Bernard J. Gersh, Harry Rakowski, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD!

Presenter: Bernard J. Gersh, Harry Rakowski, George S. Hanzel

October 30, 2016

Presentation TCT 2016

When Is Pacing Needed in HCM Outside Invasive Management Settings

Presenter: Bernard J. Gersh, Harry Rakowski

October 30, 2016

Presentation TCT 2016

Medical Management of Non-Obstructive HCM: When and Which Medications?

Presenter: Bernard J. Gersh, Harry Rakowski, John S. Douglas Jr

October 30, 2016

Presentation TCT 2016

Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening

Presenter: Howard C. Herrmann, Sherif F. Nagueh, Robert Roberts

October 30, 2016

Advertisement

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Is LAA Closure an Alternative to Triple Therapy for all Patients or Those at High Bleeding Risk? Current Dataset

Why Triple Therapy? Rationale and Potential Role for LAA Closure in the PCI Patient

Future Therapy for Symptomatic HCM Patients With and Without Dynamic Obstruction

Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Septal Ablation Is As Good As Surgery and Less Invasive!

Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Surgery Is Always the First Option!

Debate: Surgery, Septal Ablation or Medical Therapy for Obstructive HCM Not so Fast: Try Optimizing Medical Therapy First!

Novel Approaches for Septal Ablation: Beyond Alcohol

Alcohol Septal Ablation of Ventricular Tachycardia

An Alcohol Septal Ablation Case I Regret

My Best Alcohol Septal Ablation Case

Good and Not So Good Cases to Consider for Alcohol Septal Ablation

Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD!

When Is Pacing Needed in HCM Outside Invasive Management Settings

Medical Management of Non-Obstructive HCM: When and Which Medications?

Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content